By using this site, you agree to the Privacy Policy and Terms & Conditions.
Accept
Okay.ngOkay.ng
  • News
    • Politics
    NewsShow More
    NRC Resumes Services on Abuja-Kaduna Route After Train Derailment
    January 30, 2023
    FG lauds visa ban by US for Nigerians undermining democracy
    January 30, 2023
    DSS
    DSS busts syndicates selling new naira notes
    January 30, 2023
    L--R: Chairman of Occasions, Mrs. Ajoritsedere Awosika, President/CE, Dangote Industries limited, Aliko Dangote, with the Vanguard 2022 Personality of the year Award, Publisher of Vanguard Newspapers, Sam Amuka, at the Vanguard Newspapers 2022 Awards in Lagos on Friday 27th January 2023
    Aliko Dangote Named Vanguard’s Personality of the Year
    January 30, 2023
    House of Representative
    Reps Rejects CBN’s 10-day Extension for Old Naira Notes Exchange
    January 29, 2023
  • Entertainment
    EntertainmentShow More
    Abdulrasheed Bello (JJC Skillz)
    JJC Skillz Calls for Collaboration in Black History Month Track and Video
    January 30, 2023
    Police arrest popular Kano TikTok star
    January 29, 2023
    Singer, Chuddy K loses wife
    January 28, 2023
    Yeni Kuti
    Infidelity: I Can Only Leave if My Partner Sleeps with Another Man – Yeni Kuti
    January 27, 2023
    I was shocked when my wife offered to donate kidney – Eedris Abdulkareem
    January 27, 2023
  • Business & Economy
    Business & EconomyShow More
    House of Representative
    Reps Rejects CBN’s 10-day Extension for Old Naira Notes Exchange
    January 29, 2023
    Why the CBN Decided to Give Nigerians More Time to Exchange Old Naira Notes
    January 29, 2023
    Central Bank of Nigeria (CBN)
    Deadline for Returning Old Naira Notes Remains January 31 – CBN
    January 28, 2023
    Godwin Emefiele
    CBN Introduces Domestic Card to Combat Foreign Exchange Challenges
    January 26, 2023
    Godwin Emefiele
    CBN stands firm on January 31st deadline, says no extension for deposit of old naira notes
    January 24, 2023
  • Sport
    SportShow More
    Osimhen shines as Napoli extend lead in Serie A title race
    January 30, 2023
    Djokovic Beats Tsitsipas to Clinch 10th Australian Open Title
    January 29, 2023
    BUA Group Brings Excellence to the 2023 Lagos International Polo Tournament
    January 27, 2023
    Kolo Toure
    Kolo Toure sacked by Wigan Athletic after winless reign
    January 27, 2023
    Ex-Madrid star, Gareth Bale to make professional golf debut
    January 24, 2023
  • Tech
    TechShow More
    Kashifu Inuwa
    Forbes Recognizes NITDA’s Kashifu Inuwa with Best of Africa Corporate Governance Award
    January 16, 2023
    NCC
    NCC Returns to Television with Telecom Weekly Program
    January 10, 2023
    MTN Nigeria Launches Thryve Ads to Support SMEs in Social Media Marketing
    January 6, 2023
    WhatsApp
    WhatsApp to End Support for Dozens of Devices on Dec 31st, 2022 – See List
    December 29, 2022
    The Redmi K60 Pro: Xiaomi’s Latest 5G Smartphone with a High-Refresh-Rate Display and HDR10+ Support
    December 29, 2022
Reading: First Human Ebola Vaccine Trial Shows Success
Share
Aa
Okay.ngOkay.ng
Aa
  • News
  • Entertainment
  • Business & Economy
  • Sport
  • Tech
Search
  • News
    • Politics
  • Entertainment
  • Business & Economy
  • Sport
  • Tech
Follow US
  • About Okay.ng
  • Advertising on Okay.ng
  • Contact Okay.ng
  • Okay.ng on WhatsApp
  • Careers
  • Submit News to Okay.ng
© OKN MEDIA PUBLISHING 2022 - All rights reserved
News

First Human Ebola Vaccine Trial Shows Success

Farouk Mohammed By Farouk Mohammed Published November 27, 2014
Share
3 Min Read
SHARE

A17StX05KkMvP4RoxCs8mde3-300x168

The days of lack of vaccine for the deadly Ebola Virus Disease, EVD, may be finally over as doctors have announced that the first test of an Ebola vaccine in human shows it’s safe and appears to be working as designed.

According to the report made public on Wednesday, 26 November, 2014, a check on the first 20 people injected with the vaccine, which has been shown to protect monkeys from Ebola, shows no dangerous side effects.

It also added that the vaccine seems to be producing an immune response that would be expected to protect them from infection.

- Advertisement -

“This response is very comparable to the level of the response that actually protected the animals,” said Dr. Tony Fauci, head of the National Institute for Allergy and Infectious Diseases, NIAID, which helped develop and test the vaccine.

The Ebola virus is currently raging through Sierra Leone, Liberia and Guinea and according to the World Health Organisation, WHO, the disease has killed more than 5,000 people and infected 15,000 others.

It was disclosed that NIAID is working with vaccine maker GlaxoSmithKline to develop the vaccine, which uses a common cold virus called an adenovirus that normally infects chimpanzees and doesn’t cause any symptoms in humans.

It was gathered that the vaccine is genetically engineered with a small piece of Ebola virus and, in theory, should prompt the immune system to recognize and attack Ebola.

The report stated that the trial is designed to see if the vaccine is safe and if the immune system responds in a way that would be expected to protect them.

The vaccine did, the NIAID researchers report in the New England Journal of Medicine.

They especially looked at immune cells called CD8 T-cells.

“We know from previous studies in non-human primates that CD8 T-cells played a crucial role in protecting animals that had been vaccinated with this NIAID/GSK vaccine and then exposed to otherwise lethal amounts of Ebola virus,” said Dr. Julie Ledgerwood, an NIAID researcher who led the trial.

She added: “The size and quality of the CD8 T-cell response we saw in this trial are similar to that observed in non-human primates vaccinated with the candidate vaccine.”

It was disclosed that the real test will come if and when the vaccine is used to protect doctors, nurses and other health care workers who treat actual Ebola patients.

The WHO says 588 health care workers have been infected with Ebola and 337 have died of it.

Officials of the health agency stated that they hope to be able to use at least one of the vaccines to start immunizing health care workers by January.

Share this Article
Facebook Twitter Whatsapp Whatsapp Telegram Email Copy Link Print
What do you think?
Happy0
Love0
Sad0
Angry0
Joy0
Surprise0

Connect with Okay on Social

Facebook Like
Twitter Follow
Instagram Follow
Telegram Follow
- Advertisement -
Ad imageAd image
- Advertisement -
Ad imageAd image
- Advertisement -
Ad imageAd image

Recent Posts

FIRS makes FAAC Fat
Opinion
NRC Resumes Services on Abuja-Kaduna Route After Train Derailment
News
Abdulrasheed Bello (JJC Skillz)
JJC Skillz Calls for Collaboration in Black History Month Track and Video
Entertainment
FG lauds visa ban by US for Nigerians undermining democracy
News
DSS
DSS busts syndicates selling new naira notes
News
- Advertisement -

You Might Also Like

News

NRC Resumes Services on Abuja-Kaduna Route After Train Derailment

January 30, 2023
News

FG lauds visa ban by US for Nigerians undermining democracy

January 30, 2023
DSS
News

DSS busts syndicates selling new naira notes

January 30, 2023
L--R: Chairman of Occasions, Mrs. Ajoritsedere Awosika, President/CE, Dangote Industries limited, Aliko Dangote, with the Vanguard 2022 Personality of the year Award, Publisher of Vanguard Newspapers, Sam Amuka, at the Vanguard Newspapers 2022 Awards in Lagos on Friday 27th January 2023
News

Aliko Dangote Named Vanguard’s Personality of the Year

January 30, 2023
Previous Next
Okay.ngOkay.ng
Follow US

© OKN MEDIA PUBLISHING 2022 - All rights reserved

  • About Okay.ng
  • Advertising on Okay.ng
  • Contact Okay.ng
  • Okay.ng on WhatsApp
  • Careers
  • Submit News to Okay.ng
Welcome Back!

Sign in to your account

Lost your password?